SCHEMBL7559199

SCHEMBL7559199

CSCC[C@H](N)C(=O)Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.52
ITGA2B P08514 2/20 0.52
FNTA P49354 3/20 0.46
FNTB P49356 3/20 0.46
PGGT1B P53609 3/20 0.46
LMNA P02545 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GNPAT O15228 1/20 0.42
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180586 0.87 PTPN1 (0.48) ITGB3ITGA2BFNTAFNTBPGGT1B
SCHEMBL8938060 0.85 ITGB3 (0.57) ITGB3ITGA2BLMNAALDH1A1GNPAT
SCHEMBL10614969 0.84 FNTA (0.43) FNTAFNTBPGGT1BKMT2AMME
Acetyl Tyrosine SCHEMBL27781509 0.83 SLC7A5 (0.54) ITGB3ITGA2BLMNAGNPATMME
SCHEMBL7560095 0.83 ITGB3 (0.55) ITGB3ITGA2BLMNAALDH1A1KMT2A
Aspartic Acid SCHEMBL27954511 0.82 PTPN1 (0.43) ITGB3ITGA2BFNTAFNTBPGGT1B
Aspartic Acid SCHEMBL2473894 0.82 PTPN1 (0.43) ITGB3ITGA2BFNTAFNTBPGGT1B
Aspartic Acid SCHEMBL28937732 0.82 PTPN1 (0.43) ITGB3ITGA2BFNTAFNTBPGGT1B
Leucine SCHEMBL1724133 0.81 PTPN1 (0.43) ITGB3ITGA2BFNTAFNTBPGGT1B
Acetyl Tyrosine SCHEMBL7559190 0.81 SLC7A5 (0.48) ITGB3ITGA2BLMNAALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137124-A1 Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase INSTITUTO SUPERIOR TECHNICO (PT) 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137124-A1 Process for the continuous production of dipeptide crystals in a membrane and hydro-cyclone reactor using a peptidase LCT, PEPD, CPN1 ITGB3 4862/4885ITGA2B 4867/4885FNTA 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.